Suit filed against Uber and others after allegedly suffering a violent attack at the hands of a hailed driver in downtown ...

Sujal Patel, CEO of Nautilus Biotechnology Nautilus CEO Sujal Patel. (Nautilus Photo) Patel previously helped launch and lead Isilon Systems, which sold to EMC for $2.25 billion in 2010.

Biotech-startup CEOs are taking more nuanced approaches to going public amid a downturn. Insider talked to the leaders of five privately held biotechs for their views on IPOs in 2023.

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.